Indo Global Exchanges Pte Ltd (IGEX)

[Daguvanuh]

so the bear case is, no approvals yet, no revenue stream, all filings are not completed yet...
Obvious overlooking, patents, drugs in trials, existing bio technology, and now New company in an old Stock company shell, since it is cheaper than start up process of going public.
What the missing point here is.. This is priced under 1 cent. Way under 1 cent.
Give it approval, revenue, current filings and earnings, where will it be? That is what the bears say it is missing here. They act as the PPS is $12 a share... Guys it's NOT. It is sub penny still.